| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5912391 | Multiple Sclerosis and Related Disorders | 2014 | 8 Pages |
Abstract
The results suggest that NAb testing reduces relapses and associated costs.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Evelyn Walter, Florian Deisenhammer,